To present a framework of widely used evidence-based clinical practice guidelines and landmark randomized trials that inform diagnosis, management, and treatment decisions in otolaryngology.
Approach:
AAO–HNS Clinical Practice Guideline: Adult Sinusitis: The AAO–HNS updated its Clinical Practice Guideline: Adult Sinusitis to include recommendations for diagnostic testing, watchful waiting for uncomplicated acute bacterial rhinosinusitis, antibiotic therapy, and management of chronic rhinosinusitis, including biologic therapy for chronic rhinosinusitis with nasal polyps.
AAO–HNS Clinical Practice Guideline: Sudden Hearing Loss: The guideline emphasizes obtaining audiometry within 14 days of symptom onset, evaluating for retrocochlear pathology, and the use of corticosteroids and hyperbaric oxygen therapy.
AAO–HNS Clinical Practice Guideline: Tonsillectomy in Children: The guideline includes recommendations for indications for surgery, assessment of obstructive sleep-disordered breathing, and postoperative follow-up, while advising against perioperative antibiotics and codeine for children under 12.
Veterans Affairs Laryngeal Cancer Study: The study found that induction chemotherapy followed by radiation therapy preserved the larynx in 64% of patients without compromising overall survival.
Ménière Disease Clinical Practice Guideline: The guideline aims to improve diagnostic evaluation and treatment of Ménière disease, focusing on reducing unindicated testing and managing symptoms.
RTOG 91-11 Trial: The trial showed that concurrent cisplatin with radiotherapy achieved higher rates of laryngeal preservation compared to other treatment modalities.
ORATOR Trial: The trial noted differences in quality of life and toxicity between radiotherapy and transoral robotic surgery for oropharyngeal cancer.
RTOG 91-11 Long-Term Follow-up: The follow-up indicated improved laryngectomy-free survival with certain chemotherapy and radiotherapy combinations.
Key Findings:
Updated guidelines reflect new evidence in the management of various otolaryngological conditions.
Induction chemotherapy can preserve the larynx without compromising survival in laryngeal cancer.
Concurrent cisplatin with radiotherapy improves laryngeal preservation and locoregional control.
Quality of life outcomes differ between surgical and non-surgical treatments for oropharyngeal cancer.
Interpretation:
The article summarizes key evidence-based guidelines and trials that shape clinical practice in otolaryngology, emphasizing the importance of updated recommendations based on recent research.
Limitations:
The article does not provide detailed methodologies of the studies referenced.
Specific outcomes and statistical analyses from the trials are not included.
Conclusion:
The framework serves as a resource for clinicians in otolaryngology to inform their practice based on the latest evidence.
